InnoCare Presents Orelabrutinib Data at ESMO Congress
InnoCare Pharma said the latest data for its BTK inhibitor orelabrutinib were presented at the European Society for Medical Oncology Congress 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
InnoCare Pharma Presents Orelabrutinib Data at ESMO Congress
InnoCare Pharma said data on orelabrutinib were presented at the European Society for Medical Oncology Congress 2026.